Oxford Financial Group LTD Elanco Animal Health Inc Transaction History

Oxford Financial Group LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	SELL	$12.41 - $32.42 $62 - $162	-5 Reduced 0.05%	10,219 $127,000
Q2 2022 Aug 11, 2022	BUY	$19.63 - $26.62 $98 - $133	5 Added 0.05%	10,224 $201,000
Q1 2021 May 10, 2021	SELL	$27.85 - $34.49 $150,278 - $186,108	-5,396 Reduced 34.56%	10,219 $301,000
Q4 2020 Feb 10, 2021	BUY	$27.53 - $33.79 $179,991 - $220,919	6,538 Added 72.03%	15,615 $479,000
Q3 2020 Nov 12, 2020	BUY	$21.1 - $29.13 $191,524 - $264,413	9,077 New	9,077 $254,000
Q2 2020 Aug 05, 2020	SELL	$18.94 - $24.93 $171,918 - $226,289	-9,077 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$16.68 - $32.25 $151,404 - $292,733	9,077 New	9,077 $203,000

437

473M

4.62M

753K

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $5.42B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

Get notified when there are updates to the investment portfolio of Oxford Financial Group LTD, based on Form 13F filings with the SEC.

Stay updated on Oxford Financial Group LTD with notifications on news.